Background/Objectives: Capsular contracture remains the most common complication after breast augmentation. The Baker score is a classical, yet subjective method to assess the contracture, therefore more objective and reproducible measures are necessary to not only evaluate but also to predict a capsule formation. The aim of the prospective study was to assess the predictive value of sonoelastography, tonometry and physical examination at different time points after the surgery and with association with Baker score, since this early period is considered critical for the initiation of capsular formation. Methods: 28 patients (range of age 21.0–40.0) after breast augmentation completed the study protocol. A total of 56 breasts underwent clinical (modified Baker score), tonometric, and elastographic evaluation before surgery, on postoperative days 7 and 14, and after one year. Measurements were taken at the boundaries of the four breast quadrants and included adipose, glandular, muscular and fascial tissues. Results: At long-term follow-up, tonometric and elastographic values were lower than on postoperative days 7 and 14. Early measurements in certain quadrants and tissue regions showed some association with Baker scores at one year. All tissues increased in stiffness postoperatively and remained stiffer at the 1-year follow-up. No significant differences in tissue stiffness were observed between days 7 and 14, except for higher values in adipose tissue in the inner quadrant and lower values at the peri-implant region in the outer quadrant. Conclusions: Sonoelastography is a precise and objective tool for detecting capsular changes after breast augmentation and may improve early prediction of contracture.

Background/Objectives: The Diet Quality Questionnaire (DQQ) is a brief, food group–based instrument designed for globally comparable population surveillance of diet quality. We culturally adapted the DQQ for Poland and evaluated its internal structure and reliability in an adult cohort. Methods: Following forward–backward translation and expert review, the Polish DQQ was administered online to adult females. Internal structure was explored and test–retest reliability was assessed for total DQQ scores. Diet quality indicators (Dietary Diversity Score [DDS], NCD-protect, NCD-risk, and Global Dietary Recommendations score [GDR]) were summarized descriptively. Results: The average age in the cohort was 29.4 ± 13.6 years. A total of 296 respondents completed the survey; 100 completed the retest. Item-level test–retest reliability was good to excellent (Cohen’s kappa 0.72–1.00). Agreement for total scores was high with minimal bias (Bland–Altman bias 0.2, >95% of observations within limits of agreement) and there was no heteroscedasticity; Passing–Bablok regression indicated equivalence between the test and retest. Median (IQR) diet quality indicators were: DDS 6.0 (5.0; 7.0), NCD-protect 2.5 (1.5; 4.0), NCD-risk 2.5 (1.0; 4.0), and GDR 9.0 (7.5; 10.5). Eighty percent met DDS ≥ 5, while one-third consumed all five recommended food groups. Conclusions: DQQ-PL demonstrates high item-level stability and strong agreement for total scores, with structural findings aligning with its design as a non-latent, food group checklist for population monitoring. The Polish adaptation is feasible and reliable in the studied population (young adult women), supporting its potential use for rapid dietary surveillance pending broader validation.

Background: Peri-implant capsular formation remains a multifactorial process influenced by implant characteristics and patient-specific tissue responses. Ultrasound with shear-wave elastography offers evaluation of the biomechanical properties of both the capsule and surrounding breast tissues. Elastographic assessment does not distinguish intrinsic stiffness from the amount of fibrotic tissue. We introduced the Elasticity per Thickness Index (ETI) as an exploratory measure of capsular stiffness related to capsule thickness. Methods: This prospective study assessed peri-implant capsules and adjacent breast tissue compartments using B-mode ultrasound and shear-wave elastography over more than two years of follow-up. Capsular stiffness, thickness, and the exploratory Elasticity per Thickness Index (ETI; kPa/mm) were compared across implant characteristics, and their associations with clinical variables were analyzed. Results: Significant postoperative increases in stiffness were found across multiple native tissue compartments. Breast tissues remained on average stiffer than preoperatively throughout follow-up. Implant type or shape (F and M series, L3, MP EU, HP EU; anatomical vs. round) showed no association with stiffness changes, although round implants tended to yield higher fascial stiffness (p = 0.080). The ETI was independent of implant shape (p = 0.430). Higher-profile implants showed a nominally higher ETI than medium-profile implants (39.1 ± 13.4 vs. 31.9 ± 13.4 kPa/mm; unadjusted p = 0.050), which should be interpreted as an exploratory finding. The ETI was not significantly associated with implant profile after accounting for bilateral clustering (p = 0.455). Capsular stiffness was inversely associated with time from surgery to assessment (Rs = −0.329, p = 0.013), although this cross-sectional association does not demonstrate longitudinal softening. Conclusions: At the postoperative assessment, the peri-implant capsule showed a mean stiffness of 15.52 ± 3.81 kPa. The ETI may provide a complementary thickness-related description of capsular stiffness, although its reliability and clinical relevance require further validation. No robust association between implant profile and the ETI was identified after accounting for bilateral clustering.

Sarcopenia, low muscle mass, and low muscle radiodensity are increasingly being considered factors associated with treatment outcomes in patients with gynecological malignancies. Despite the growing body of evidence, body composition assessment is not routinely incorporated into clinical practice. The aim of this review was to present current evidence on the associations of muscle parameters with survival, complications, systemic treatment toxicity, and quality of life, as well as to discuss the opportunities and limitations of computed tomography (CT) and bioelectrical impedance analysis (BIA) in body composition monitoring. A narrative literature review was conducted using the PubMed, Scopus, and Web of Science databases, primarily covering publications from 2019 to 2026, together with earlier studies relevant to the topic. Systematic reviews, meta-analyses, and selected observational, longitudinal, and interventional studies were included. The available evidence indicates that low muscle mass and low muscle radiodensity are primarily associated with poorer overall survival and an increased risk of selected postoperative complications. Evidence regarding progression-free survival, disease recurrence, chemotherapy toxicity, and quality of life remains less consistent. Low muscle mass may occur independently of body weight and body mass index (BMI); therefore, routine anthropometric assessment may fail to identify adverse changes in body composition. CT image analysis enables quantitative assessment of muscle mass and evaluation of muscle radiodensity, whereas BIA may serve as a complementary tool for repeated body composition monitoring. However, its use is limited by the effects of hydration status, edema, and ascites, as well as by the lack of validated cut-off values for patients with gynecological malignancies. Body composition assessment should be interpreted in conjunction with evaluations of muscle strength, physical performance, nutritional status, treatment toxicity, and quality of life. Prospective studies are needed to determine whether body composition monitoring and the implementation of targeted supportive care improve treatment tolerance and clinical outcomes.

Introduction: Postoperative pain after silicone breast augmentation is influenced by multiple patient- and procedure-related factors, yet limited research has directly evaluated these variables. Understanding predictors of pain may improve analgesic strategies and patient outcomes. The aim of this study was to identify patient- and procedure-related predictors of postoperative pain following elective silicone breast augmentation. Material and methods: This prospective study enrolled 35 women undergoing elective breast augmentation with silicone gel-filled implants; 28 completed the 14-day protocol. Preoperative questionnaires collected data on age, parity, breastfeeding duration, handedness, hormonal contraception use, satisfaction, and physical activity. Implant characteristics (type, shape, volume) and operative parameters were also analyzed. Patients recorded daily pain for each breast using a 10 cm visual analogue scale (VAS). Results: Mean VAS pain scores decreased from 79 mm on postoperative day 1 to below 15 mm by day 7, remaining near zero thereafter. Larger implant volume was associated with slightly lower pain on days 1–3. Age negatively correlated with pain on days 13–14. No significant associations were observed with parity, breastfeeding duration, hormonal contraception, physical activity (except day 11), surgical duration, or handedness. Anatomical implants were initially associated with higher early pain scores compared with round implants, but mean pain at day 14 did not differ according to implant type, shape, or height profile. Conclusions: Postoperative pain following breast augmentation is multifactorial. Most patient- and procedure-related variables, including implant type and model, had a limited long-term impact. Detailed pain monitoring may guide individualized analgesic strategies, optimize perioperative care, and support opioid-sparing approaches.